Instem has announced the selection of Provantis preclinical software solution by a Japanese research-oriented global pharmaceutical company for its Osaka R&D facility.

 

The comprehensive suite of modules will support the areas of general toxicology, reproductive toxicology, pathology and pharmacy.

 

The project also includes a systems integration component, replacing a legacy solution, according to Instem.

 

Instem will work in close co-operation with CTCLS, its Japanese distributor, for a successful deployment.

 

Instem European and Asian Operations VP Neil Donaldson said, "This is excellent news for both CTCLS and Instem, and demonstrates the winning combination of global technology leadership and local support that we offer to organizations throughout Japan."